Skip to main content

Table 3 Association between disease symptoms and disease outcome

From: Outcome evaluation of COVID-19 infected patients by disease symptoms: a cross-sectional study in Ilam Province, Iran

Symptoms

Discharge

Death

X2

P-value

Shortness of breath or difficulty breathing

22.8%

56.6%

77.26

< 0.0001**

Abnormal findings of chest radiography

1.7%

10.1%

42.81

< 0.0001**

Persistent pain or pressure in the chest

1.4%

4.7%

8.52

0.004**

Sore throat

27.0%

11.6%

15.02

< 0.0001**

Headache*

10.1%

2.3%

8.45

0.001**

Diarrhea*

3.5%

0.0%

4.66

0.02**

Muscle or body aches

12.0%

3.9%

7.89

0.005**

Fever or chills

24.7%

17.8%

3.17

0.075

Eye redness*

0.3%

0.0%

0.36

1.00

Cough

39.3%

39.5%

0.002

0.96

General weakness

6.2%

9.3%

2.004

0.15

Nausea or vomiting*

3.5%

2.3%

0.48

0.62

Conjunctivitis*

2.7%

2.3%

0.059

1.00

New confusion*

2.6%

0.8%

1.65

0.37

*Abnormal lung sound

0.1%

0.8%

3.45

0.18

Stomach ache*

1.6%

0.0%

2.105

0.26

Congestion or runny nose*

0.6%

0.0%

0.81

1.00

External pharynx*

0.6%

0.0%

0.73

1.00

  1. *In cases where expected counts were less than 5, Fisher’s exact test was used instead of the Chi-square test
  2. **P < 0.05 was considered as significant